| dc.contributor.author | Wischik, Claude M | |
| dc.contributor.author | Harrington, Charles R | |
| dc.contributor.author | Storey, John M D | |
| dc.date.accessioned | 2015-01-27T11:16:02Z | |
| dc.date.available | 2015-01-27T11:16:02Z | |
| dc.date.issued | 2014-04-15 | |
| dc.identifier | 45921625 | |
| dc.identifier | 42ebfe5d-661c-4849-b71d-c7283f13fc04 | |
| dc.identifier | 24361915 | |
| dc.identifier | 84898059466 | |
| dc.identifier.citation | Wischik , C M , Harrington , C R & Storey , J M D 2014 , ' Tau-aggregation inhibitor therapy for Alzheimer's disease ' , Biochemical Pharmacology , vol. 88 , no. 4 , pp. 529-539 . https://doi.org/10.1016/j.bcp.2013.12.008 | en |
| dc.identifier.issn | 0006-2952 | |
| dc.identifier.other | ORCID: /0000-0002-5261-5467/work/73579087 | |
| dc.identifier.uri | http://hdl.handle.net/2164/4208 | |
| dc.format.extent | 11 | |
| dc.format.extent | 1341784 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Biochemical Pharmacology | en |
| dc.subject | Alzheimer's disease | en |
| dc.subject | Amyloid | en |
| dc.subject | Methylthioninium | en |
| dc.subject | Tau | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject.lcc | RM | en |
| dc.title | Tau-aggregation inhibitor therapy for Alzheimer's disease | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Chemistry | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1016/j.bcp.2013.12.008 | |
